Time-course analysis of pica in rats using an automatic feeding monitoring system

Journal of Pharmacological and Toxicological Methods

Volumn 63, Issue 1, 2011, Pages 30-34

  Yamamoto, Kouichi ^a   Asano, Keiko ^a   Matsukawa, Naoki ^a   Imaizumi, Masahiro ^b   Yamatodani, Atsushi ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Research and Engineering   (Japan)

Author keywords

Automatic feeding monitoring system; Emetic stimuli; Nausea; Pica; Rats; Vomiting

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; GRANISETRON; KAOLIN;

ANIMAL EXPERIMENT; ANOREXIA; ARTICLE; CHEMOTHERAPY INDUCED EMESIS; CONTROLLED STUDY; FOOD INTAKE; LATENT PERIOD; MALE; MONITORING; NAUSEA AND VOMITING; NONHUMAN; PICA; RAT; TIME SERIES ANALYSIS; WHOLE BODY RADIATION;

ANIMALS; ANTINEOPLASTIC AGENTS; EATING; FEEDING BEHAVIOR; FEEDING METHODS; GRANISETRON; KAOLIN; MALE; NAUSEA; PICA; RATS; RATS, WISTAR; SEROTONIN ANTAGONISTS; TIME FACTORS; VOMITING; X-RAYS;

ANIMALIA; RATTUS;

EID: 78650768307     PISSN: 10568719     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vascn.2010.04.011     Document Type: Article

References (33)

1. Prevention of chemotherapy- and radiotherapy-induced emesis: Results of Perugia Consensus Conference. Annals of Oncology 1998, 9:811-819. Antiemetic Subcommittee of the Multinational Association of Supportive Care in Cancer (MASCC).
2. ASHP Therapeutic guidelines on the pharmacologic management of nausea and vomiting in adult and pediatric patients receiving chemotherapy or radiation therapy or undergoing surgery. American Journal of Health-System Pharmacy 1999, 56:729-764.
3. Barrett A. Total body irradiation (TBI) before bone marrow transplantation in leukaemia: A co-operative study from the European Group for Bone Marrow Transplantation. British Journal of Radiology 1982, 55:562-567.
4. Buchali A., Feyer P., Groll J., Massenkeil G., Arnold R., Budach V. Immediate toxicity during fractionated total body irradiation as conditioning for bone marrow transplantation. Radiotherapy and Oncology 2000, 54:157-162.
5. Cassidy J., Raina V., Lewis C., Adams L., Soukop M., Rapeport W.G., et al. Pharmacokinetics and anti-emetic efficacy of BRL43694, a new selective 5HT-3 antagonist. British Journal of Cancer 1988, 58:651-653.
6. Cubeddu L.X. Mechanisms by which cancer chemotherapeutic drugs induce emesis. Seminars in Oncology 1992, 19(6 Suppl):2-13.
7. De Jonghe B.C., Horn C.C. Chemotherapy-induced pica and anorexia are reduced by common hepatic branch vagotomy in the rat. American Journal of Physiology: Regulatory, Integrative and Comparative Physiology 2008, 294:R756-R765.
8. De Jonghe B.C., Lawler M.P., Horn C.C., Tordoff M.G. Pica as an adaptive response: Kaolin consumption helps rats recover from chemotherapy-induced illness. Physiology & Behavior 2009, 97:87-90.
9. de Wit R., Herrstedt J., Rapoport B., Carides A.D., Carides G., Elmer M., et al. Addition of the oral NK1 antagonist aprepitant to standard antiemetics provides protection against nausea and vomiting during multiple cycles of cisplatin-based chemotherapy. Journal of Clinical Oncology 2003, 21:4105-4111.
10. Feyer P.C., Stewart A.L., Titlbach O.J. Aetiology and prevention of emesis induced by radiotherapy. Supportive Care in Cancer 1998, 6:253-260.
11. Goodman M. Risk factors and antiemetic management of chemotherapy-induced nausea and vomiting. Oncology Nursing Forum 1997, 24:20-32. (suppl).
12. Halsted J.A. Geophagia in man: Its nature and nutritional effects. American Journal of Clinical Nutrition 1968, 21:1384-1393.
13. Herrstedt J. Antiemetics: An update and the MASCC guidelines applied in clinical practice. Nature Clinical Practice Oncology 2008, 5:32-43.
14. Hesketh P.J., Kris M.G., Grunberg S.M., Beck T., Hainsworth J.D., Harker G., et al. Proposal for classifying acute emetogenicity of cancer chemotherapy. Journal of Clinical Oncology 1997, 15:103-109.
15. Hickok J.T., Roscoe J.A., Morrow G.R., King D.K., Atkins J.N., Fitch T.R. Nausea and emesis remain significant problems of chemotherapy despite prophylaxis with 5-hydroxytryptamine-3 antiemetics: A University of Rochester James P. Wilmot Cancer Center Community Clinical Oncology Program Study of 360 cancer patients treated in the community. Cancer 2003, 97:2880-2886.
16. Johns T., Duquette M. Detoxification and mineral supplementation as functions of geophagy. American Journal of Clinical Nutrition 1991, 53:448-456.
17. Jordan K., Kasper C., Schmoll H.J. Chemotherapy-induced nausea and vomiting: Current and new standards in the antiemetic prophylaxis and treatment. European Journal of Cancer 2005, 41:199-205.
18. Jordan K., Sippel C., Schmoll H.J. Guidelines for antiemetic treatment of chemotherapy-induced nausea and vomiting: Past, present, and future recommendations. Oncologist 2007, 12:1143-1150.
19. King G.L. Animal models in the study of vomiting. Canadian Journal of Physiology and Pharmacology 1990, 68:260-268.
20. Kirkbride P., Bezjak A., Pater J., Zee B., Palmer M.J., Wong R., et al. Dexamethasone for the prophylaxis of radiation-induced emesis: A National Cancer Institute of Canada Clinical Trials Group phase III study. Journal of Clinical Oncology 2000, 18:1960-1966.
21. Malik, N. M., Liu, Y. L., Cole, N., Sanger, G. J., & Andrews, P. L. (2007). Differential effects of dexamethasone, ondansetron and a tachykinin NK1 receptor antagonist (GR205171) on cisplatin-induced changes in behaviour, food intake, pica and gastric function in rats. European Journal of Pharmacology, 555, 164-173.
22. Matsuki N., Ueno S., Kaji T., Ishihara A., Wang C.H., Saito H. Emesis induced by cancer chemotherapeutic agents in the Suncus murinus: A new experimental model. Japanese Journal of Pharmacology 1988, 48:303-306.
23. Naylor R.J., Rudd J.A. Mechanisms of chemotherapy/radiotherapy-induced emesis in animal models. Oncology 1996, 53(Suppl 1):8-17.
24. Nelson K., Walsh D., Sheehan F. Cancer and chemotherapy-related upper gastrointestinal symptoms: The role of abnormal gastric motor function and its evaluation in cancer patients. Supportive Care in Cancer 2002, 10:455-461.
25. Roila F., Donati D., Tamberi S., Margutti G. Delayed emesis: Incidence, pattern, prognostic factors and optimal treatment. Supportive Care in Cancer 2002, 10:88-95.
26. Roila F., Hesketh P.J., Herrstedt J. Antiemetic Subcommitte of the Multinational Prevention of chemotherapy- and radiotherapy-induced emesis: Results of the 2004 Perugia International Antiemetic Consensus Conference. Annals of Oncology 2006, 17:20-28.
27. Rudd J.A., Naylor R.J. An interaction of ondansetron and dexamethasone antagonizing cisplatin-induced acute and delayed emesis in the ferret. British Journal of Pharmacology 1996, 118:209-214.
28. Takeda N., Hasegawa S., Morita M., Matsunaga T. Pica in rats is analogous to emesis: An animal model in emesis research. Pharmacology, Biochemistry and Behavior 1993, 45:817-821.
29. Tramer M.R., Reynolds D.J., Stoner N.S., Moore R.A., McQuay H.J. Efficacy of 5-HT3 receptor antagonists in radiotherapy-induced nausea and vomiting: A quantitative systematic review. European Journal of Cancer 1998, 34:1836-1844.
30. Vera G., Chiarlone A., Martín M.I., Abalo R. Altered feeding behaviour induced by long-term cisplatin in rats. Autonomic Neuroscience 2006, 30:81-92.
31. Yamamoto K., Nakai M., Nohara K., Yamatodani A. The anti-cancer drug-induced pica in rats is related to their clinical emetogenic potential. European Journal of Pharmacology 2007, 554:34-39.
32. Yamamoto K., Ngan M.P., Takeda N., Yamatodani A., Rudd J.A. Differential activity of drugs to induce emesis and pica behavior in Suncus murinus (house musk shrew) and rats. Physiology and Behavior 2004, 83:151-156.
33. Yamamoto K., Takeda N., Yamatodani A. Establishment of an animal model for radiation-induced vomiting in rats using pica. Journal of Radiation Research (Tokyo) 2002, 43:135-141.